Stuart Chaussee & Associates’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-770
| Closed | -$64.6K | – | 92 |
|
|
2025
Q3 | $64.6K | Hold |
770
| – | – | 0.01% | 80 |
|
|
2025
Q2 | $61K | Hold |
770
| – | – | 0.01% | 77 |
|
|
2025
Q1 | $69.1K | Hold |
770
| – | – | 0.02% | 68 |
|
|
2024
Q4 | $76.6K | Hold |
770
| – | – | 0.02% | 64 |
|
|
2024
Q3 | $87.4K | Hold |
770
| – | – | 0.02% | 50 |
|
|
2024
Q2 | $95.3K | Hold |
770
| – | – | 0.03% | 46 |
|
|
2024
Q1 | $102K | Hold |
770
| – | – | 0.03% | 43 |
|
|
2023
Q4 | $83.9K | Buy |
770
+200
| +35% | +$20.8K | 0.02% | 43 |
|
|
2023
Q3 | $58.7K | Hold |
570
| – | – | 0.02% | 44 |
|
|
2023
Q2 | $65.8K | Hold |
570
| – | – | 0.02% | 42 |
|
|
2023
Q1 | $60.6K | Hold |
570
| – | – | 0.02% | 37 |
|
|
2022
Q4 | $63.2K | Hold |
570
| – | – | 0.02% | 37 |
|
|
2022
Q3 | $49K | Hold |
570
| – | – | 0.11% | 33 |
|
|
2022
Q2 | $52K | Hold |
570
| – | – | 0.11% | 34 |
|
|
2022
Q1 | $47K | Sell |
570
-63
| -10% | -$4.97K | 0.02% | 49 |
|
|
2021
Q4 | $49K | Hold |
633
| – | – | 0.02% | 47 |
|
|
2021
Q3 | $48K | Hold |
633
| – | – | 0.07% | 38 |
|
|
2021
Q2 | $49K | Sell |
633
-30
| -5% | -$2.23K | 0.02% | 45 |
|
|
2021
Q1 | $49K | Hold |
663
| – | – | 0.02% | 50 |
|
|
2020
Q4 | $52K | Buy |
663
+209
| +46% | +$16K | 0.02% | 46 |
|
|
2020
Q3 | $36K | Buy |
454
+140
| +45% | +$11K | 0.02% | 48 |
|
|
2020
Q2 | $23K | Hold |
314
| – | – | 0.01% | 43 |
|
|
2020
Q1 | $23K | Buy |
314
+129
| +70% | +$10.1K | 0.02% | 41 |
|
|
2019
Q4 | $16K | Hold |
185
| – | – | 0.01% | 66 |
|
|
2019
Q3 | $15K | Hold |
185
| – | – | 0.01% | 71 |
|
|
2019
Q2 | $15K | Hold |
185
| – | – | 0.01% | 73 |
|
|
2019
Q1 | $15K | Hold |
185
| – | – | 0.01% | 74 |
|
|
2018
Q4 | $14K | Hold |
185
| – | – | 0.01% | 56 |
|
|
2018
Q3 | $13K | Hold |
185
| – | – | 0.01% | 81 |
|
|
2018
Q2 | $11K | Hold |
185
| – | – | 0.01% | 88 |
|
|
2018
Q1 | $10K | Hold |
185
| – | – | 0.04% | 57 |
|
|
2017
Q4 | $10K | Hold |
185
| – | – | 0.01% | 69 |
|
|
2017
Q3 | $11K | Hold |
185
| – | – | 0.01% | 62 |
|
|
2017
Q2 | $11K | Hold |
185
| – | – | 0.01% | 59 |
|
|
2017
Q1 | $11K | Sell |
185
-25
| -12% | -$1.52K | 0.01% | 60 |
|
|
2016
Q4 | $12K | Buy |
+210
| New | +$12.3K | 0.01% | 50 |
|
Other funds holding MRK
Stuart Chaussee & Associates's MRK Position: Q4 2025 in Review
Stuart Chaussee & Associates sold out of Merck (MRK) in Q4 2025, closing a stake of 770 shares — an estimated $64.6K sold.
Stuart Chaussee & Associates first reported a position in MRK in Q4 2016 and held it in 36 quarters. The position peaked at $102K in Q1 2024. 3,660 funds tracked by Wall St. Rank hold MRK as of Q4 2025.
- Stuart Chaussee & Associates reported no remaining Merck position as of Q4 2025 after selling out during the quarter.
- Stuart Chaussee & Associates sold 770 Merck shares in Q4 2025, an estimated $64.6K.
- Stuart Chaussee & Associates first reported a position in Merck in Q4 2016 and held it in 36 quarters.
- Stuart Chaussee & Associates's Merck position peaked at $102K in Q1 2024.
- 3,660 funds tracked by Wall St. Rank held Merck as of Q4 2025.
Based on Stuart Chaussee & Associates's 13F filing for Q4 2025.